1-58. (canceled)
59. A method of reducing the rate of relapse, delaying relapse, andor preventing relapse of herpes labialis in a patient, comprising topically administering a therapeutically effective amount of: polyethylene glycol or a composition comprising polyethylene glycol; wherein the method is performed for a duration of at least 4 weeks.
60. A method according to claim 59, which is a method of reducing the rate of relapse of herpes labialis in a patient, comprising topically administering to said patient a therapeutically effective amount of: polyethylene glycol or a composition comprising polyethylene glycol.
61. A method according to claim 59, which is a method of delaying relapse of herpes labialis in a patient, comprising topically administering to said patient a therapeutically effective amount of: polyethylene glycol or a composition comprising polyethylene glycol.
62. A method according to claim 59, which is a method of preventing relapse of herpes labialis in a patient, comprising topically administering to said patient a therapeutically effective amount of: polyethylene glycol or a composition comprising polyethylene glycol.
63. A method according to claim 59, wherein the method is performed for a duration of at least 8 weeks.
64. A method according to claim 59, wherein the method is performed for a duration of at least 3 months.
65. A method according to claim 59, wherein the topical administration is from once daily to five times daily.
66. A method according to claim 59, wherein the topical administration is from once daily to three times daily.
67. A method according to claim 59, wherein the topical administration is twice daily.
68. A method according to claim 59, wherein the topical administration is to one or more sites exhibiting an active viral infection or to a site where there are no signs of an active infection but where active infection is known to occur or is expected to occur.
69. A method according to claim 59, wherein the topical administration is on andor around the lips of said patient.
70. A method according to claim 59, wherein the topical administration is on at least a part of the lips and the surrounding facial skin <1 cm from the border of the lips of said patient.
71. A method according to claim 59, wherein the topical administration is on the whole of both lips of said patient.
72. A method according to claim 59, wherein the topical administration is on the whole of both lips and on the surrounding facial skin <1 cm from the border of the lips of said patient.
73. A method according to claim 59, wherein the polyethylene glycol has a weight average molecular weight (Mw) of from about 200 to about 20,000.
74. A method according to claim 59, wherein the polyethylene glycol is polyethylene glycol with a weight average molecular weight (Mw) of from about 200 to about 1,000; or polyethylene glycol with a weight average molecular weight (Mw) of from about 1,000 to about 15,000; or a mixture thereof.
75. A method of reducing the rate of relapse of herpes labialis in a patient, comprising topically administering a therapeutically effective amount of:
polyethylene glycol or a composition comprising polyethylene glycol;
wherein the method is performed for a duration of at least 4 weeks;
wherein the topical administration is from once daily to five times daily; and
wherein the topical administration is on andor around the lips of said patient.
76. A method according to claim 75, wherein the method is performed for a duration of at least 8 weeks.
77. A method according to claim 75, wherein the method is performed for a duration of at least 3 months.
78. A method according to claim 75, wherein the topical administration is from once daily to three times daily.
79. A method according to claim 76, wherein the topical administration is from once daily to three times daily.
80. A method according to claim 77, wherein the topical administration is from once daily to three times daily.
81. A method of reducing the rate of relapse of herpes labialis in a patient,
comprising topically administering a therapeutically effective amount of:
polyethylene glycol or a composition comprising polyethylene glycol;
wherein the method is performed for a duration of at least 4 weeks;
wherein the topical administration is from once daily to five times daily;
wherein the topical administration is on andor around the lips of said patient;
and wherein the polyethylene glycol has a weight average molecular weight (Mw) of from about 200 to about 20,000.
82. A method according to claim 81, wherein the method is performed for a duration of at least 8 weeks.
83. A method according to claim 81, wherein the method is performed for a duration of at least 3 months.
84. A method according to claim 81, wherein the topical administration is from once daily to three times daily.
85. A method according to claim 82, wherein the topical administration is from once daily to three times daily.
86. A method according to claim 83, wherein the topical administration is from once daily to three times daily.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
1. A chip unit comprising:
a chip comprising a substrate, a first semiconductor layer, a light emitting layer and a second semiconductor layer; and
a base;
wherein the substrate has a first positioning structure facing the base, and the base has a second position structure facing the substrate, the first positioning structure being one of a protrusion and a groove, and the second positioning structure being the other one of the protrusion and the groove, the protrusion being fittingly received in the groove.
2. The chip unit of claim 1, wherein the first positioning structure is a groove, and the second positioning structure is a protrusion.
3. The chip unit of claim 2, wherein the substrate further comprises two blocks located at two opposite sides of the groove, each block of the substrate having an area less than that of the protrusion.
4. The chip unit of claim 3, wherein the base further comprises two slots defined at two opposite sides of the protrusion, the two blocks being fittingly received in the two slots, respectively.
5. The chip unit of claim 4, wherein each slot has a depth identical to a thickness of the protrusion.
6. The chip unit of claim 1, wherein the substrate is made of nickel.
7. The chip unit of claim 1, wherein the first semiconductor layer is a P-type semiconductor layer, and the second semiconductor layer is an N-type semiconductor layer.
8. The chip unit of claim 1, wherein the chip further comprises an electrode connected to the second semiconductor layer, the electrode and the substrate being located at two opposite ends of the chip.
9. A method for manufacturing a chip unit, comprising:
making a base and a chip, the chip comprising a substrate, a first semiconductor layer, a light emitting layer and a second semiconductor layer, the base having one of a protrusion and a groove, and the substrate having the other one of the protrusion and the groove;
disposing the chip on the base by fitting the protrusion into the groove.
10. The method of claim 9, wherein base has the protrusion, and the substrate has the groove.
11. The method of claim 10, wherein the chip is made by making an original chip comprising a temporary substrate, the first semiconductor layer, the light emitting layer and the second semiconductor layer and a connecting layer.
12. The method of claim 11, wherein the connecting layer is electroplated on the first semiconductor layer.
13. The method of claim 11, wherein the chip is made by further forming a photoresist layer on the connecting layer, a part of the connecting layer being covered by the photoresist layer and another part of the connecting layer being exposed.
14. The method of claim 13, wherein the chip is made by further forming a supporting layer on the exposed another part of the connecting layer, the supporting layer and the connecting layer cooperatively forming the substrate as a monolithic piece and being made of a same metallic material.
15. The method of claim 14, wherein the supporting layer has a face flush with that a face of the photoresist layer.
16. The method of claim 14, wherein the chip is made by further removing the photoresist layer and the temporary substrate from the original chip.
17. The method of claim 16, wherein the chip is made by further forming an electrode on the second semiconductor layer after the photoresist layer and the temporary substrate are removed.
18. The method of claim 17, wherein the original chip is reversed after forming the supporting layer and before forming the electrode.
19. The method of claim 9, wherein the first semiconductor layer is a P-type semiconductor layer, and the second semiconductor layer is an N-type semiconductor layer.
20. The method of claim 9, wherein the substrate is made of nickel.